Reposted by Sarah Hedtrich
Combining a base editor, transient barrier modulation, and topical mRNA-lipid nanoparticle administration to restore clinically meaningful levels of transglutaminase 1 activity @cp-cellstemcell.bsky.social @hedtrichlab.bsky.social
www.cell.com/cell-stem-ce...
www.cell.com/cell-stem-ce...